GSK Aktie
21,98
EUR
-0,13
EUR
-0,59
%
20,09
CHF
-0,17
CHF
-0,84
%
Erwachsen handeln.
Mit dem Broker, der Top-Insights, geprüfte Analysen
und Trading ab 0 € vereint (zzgl. Spreads).
Werbung
GSK Aktie Analyse
| 24.08.17 | GSK buy | Jefferies & Company Inc. | |
| 09.08.17 | GSK buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.08.17 | GSK buy | Goldman Sachs Group Inc. | |
| 07.08.17 | GSK Hold | Deutsche Bank AG | |
| 01.08.17 | GSK Neutral | UBS AG | |
| 27.07.17 | GSK Neutral | Citigroup Corp. | |
| 27.07.17 | GSK Equal-Weight | Morgan Stanley | |
| 27.07.17 | GSK Hold | Deutsche Bank AG | |
|
Werbung
|
|||
| 27.07.17 | GSK Neutral | UBS AG | |
| 26.07.17 | GSK Strong Sell | S&P Capital IQ | |
| 26.07.17 | GSK Neutral | UBS AG | |
| 25.07.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 25.07.17 | GSK buy | Goldman Sachs Group Inc. | |
| 25.07.17 | GSK Neutral | Citigroup Corp. | |
| 25.07.17 | GSK Hold | Deutsche Bank AG | |
| 24.07.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 20.07.17 | GSK buy | Goldman Sachs Group Inc. | |
| 18.07.17 | GSK Equal-Weight | Morgan Stanley | |
| 17.07.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 13.07.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 05.07.17 | GSK Neutral | Citigroup Corp. | |
| 30.06.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 16.06.17 | GSK buy | Jefferies & Company Inc. | |
| 16.06.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 09.06.17 | GSK Neutral | UBS AG | |
| 06.06.17 | GSK Strong Sell | S&P Capital IQ | |
| 31.05.17 | GSK buy | Goldman Sachs Group Inc. | |
| 31.05.17 | GSK Hold | Deutsche Bank AG | |
| 31.05.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 26.05.17 | GSK buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 15.05.17 | GSK Neutral | UBS AG | |
| 12.05.17 | GSK Hold | Deutsche Bank AG | |
| 12.05.17 | GSK Equal-Weight | Morgan Stanley | |
| 12.05.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 05.05.17 | GSK Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 02.05.17 | GSK Equal-Weight | Morgan Stanley | |
| 27.04.17 | GSK buy | Goldman Sachs Group Inc. | |
| 27.04.17 | GSK Neutral | UBS AG | |
| 27.04.17 | GSK Hold | Deutsche Bank AG | |
| 25.04.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 20.04.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 18.04.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 12.04.17 | GSK Hold | Deutsche Bank AG | |
| 05.04.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 23.03.17 | GSK Sell | Société Générale Group S.A. (SG) | |
| 17.03.17 | GSK Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 09.03.17 | GSK buy | Jefferies & Company Inc. | |
| 09.03.17 | GSK Reduce | Kepler Cheuvreux | |
| 08.03.17 | GSK Neutral | UBS AG | |
| 08.03.17 | GSK Equal weight | Barclays Capital | |
Werbung
Werbung